General Electric CEO Larry Culp told CNBC an initial public offering (IPO) for its healthcare unit, GE Healthcare, is unlikely for 2019 following news that the company plans to sell off its biopharma business.

It costs tens of millions of dollars to approve any new therapy for use in a clinical setting, but a recent analysis published in JAMA Internal Medicine found one class of medication comes at a price more than 100-fold higher than the average: cardiovascular drugs.

The average cardiovascular surgeon drives nearly $3.7 million in net revenue each year for a hospital system, the most among 18 physician specialties included in a survey of hospital chief financial officers. Invasive cardiologists weren’t far behind, ranking No. 2 at almost $3.5 million per year.

Two U.S. senators launched a bipartisan investigation into rising insulin prices on Feb. 22, sending letters to the drug's top three manufacturers seeking information about why costs have risen so sharply in recent years.

Patients with coronary artery disease (CAD) enrolled in private insurance plans through Medicare Advantage (MA) are more likely to receive guideline-recommended medications for secondary prevention than those in fee-for-service Medicare, according to a new analysis in JAMA Cardiology. But that wasn't tied to improvements in blood pressure or cholesterol levels.

The Department of Energy’s National Nuclear Security Administration (NNSA) will negotiate with four U.S. companies to potentially fund molybdenum-99 (Mo-99) production without the use of highly enriched uranium.

About 45 percent of Americans with atherosclerotic cardiovascular disease (ASCVD) experience financial hardship related to medical bills, despite most of them having health insurance, according to a new paper published in the Journal of the American College of Cardiology.

Living in food deserts—residential areas with low net income and poor access to healthy food—was independently linked to adverse outcomes in patients with coronary artery disease in a study of nearly 5,000 subjects, researchers reported Feb. 11 in the Journal of the American Heart Association.